Molecular mechanisms for Charcot-Marie-Tooth disease and related demyelinating peripheral neuropathies

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 61, Issue , 1996, Pages 659-671

  Waener, L E ^a   Reiter, L T ^a   Murakami, T ^a   Lupski, J R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AREFLEXIA; CHROMOSOME 17P; CLINICAL FEATURE; CONFERENCE PAPER; DEMYELINATION; GENE DUPLICATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MUSCLE ATROPHY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCHWANN CELL; ARTICLE; DEMYELINATING NEUROPATHY; GENE DELETION; GENE DOSAGE; GENE FUNCTION; GENE REARRANGEMENT; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RECOMBINATION; HOMOLOGOUS RECOMBINATION; MOLECULAR GENETICS; MYELINATION; NEUROPATHY; NONHUMAN; PATHOGENESIS; PHENOTYPE; POINT MUTATION; SYMPTOM; X CHROMOSOME LINKED DISORDER;

CMT1A PROTEIN; DNA; MYELIN; MYELIN PROTEIN; PERIPHERAL MYELIN PROTEIN 22; UNCLASSIFIED DRUG;

EID: 0030428795     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.1996.061.01.066     Document Type: Conference Paper

References (115)

1. Bergoffen, J., J. Trofatter, M.A. Pericak-Vance, J.L. Haines, P.F. Chance, and K.H. Fischbeck, 1993a. Linkage localization of X-linked Charcot-Marie-Tooth disease. Am. J. Hum. Genet. 52: 312.
2. Bergoffen, J., S.S. Scherer, S. Wang, M.O. Scott, L.J. Bone, D.L. Paul, K. Chen, M.W. Lensch, P.F. Chance, and K.H. Fischbeck. 1993b. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262: 2039.
3. Blair, I.P., J. Nash, M.J. Gordon, and G.A. Nicholson. 1996. Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: First report of a de novo duplication with a maternal origin. Am. J. Hum. Genet 58: 472.
4. Blanquet-Grossard, F., D. Pham-Dinh, A. Dautigny, P. Latour, C. Bonnebouche, E. Corbillon, G. Chazot, and A. Vandenberghe. 1995. Charcot-Marie-Tooth type 1B neuropathy: Third mutation of serine 63 codon in the major peripheral myelin glycoprotein P0 gene. Clin. Genet. 48: 281.
5. Bone, L.J., N. Dahl, M.W. Lensch, P.F. Chance, T. Kelly, E. Le Guern, S. Magi, G. Parry, H. Shapiro, S. Wang, and K.H. Fischbeck. 1995. New connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease. Neurology 45: 1863.
6. Carango, P., V.L. Funanage, R.E. Quirós, C.S. Debruyn, and H.G. Marks. 1995. Overexpression of DM20 messenger RNA in two brothers with Pelizaeus-Merzbacher disease. Ann. Neurol. 38: 610.
7. Chance, P.F., N. Abbas, M.W. Lensch, L. Pentao, B.B. Roa, P.I. Patel, and J.R. Lupski. 1994. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum. Mol. Genet. 3: 223.
8. Chance, P.F., M.K. Alderson, K.A. Leppig, M.W. Lensch, N. Matsunami, B. Smith, P.D. Swanson, S.J. Odelberg, C.M. Disteche, and T.D. Bird. 1993. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 72: 143.
9. Cooper, D.N. and M. Krawczak. 1993. Human gene mutation. BIOS Scientific, Oxford.
10. Cooper, D.N. and H. Youssoufian. 1988. The CpG dinucleotide and human genetic disease. Hum. Genet. 78:151.
11. Cremers, F.P.M., R.A. Pfeiffer, T.J.R. van de Pol, M.H. Hofker, T. A. Kruse, B. Wieringa, and H.H. Ropers. 1987. An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-q22 region. Hum. Genet. 77: 23.
12. Dautigny, A., M.-G. Mattei, D. Morello, P.M. Alliel, D. Pham-Dinh, L. Amar, D. Arnaud, D. Simon, J.-F. Mattei, J.-L. Guenet, P. Jollès, and P. Avner. 1986. The structural gene coding for myelin-associated proteolipid protein is mutated in jimpy mice. Nature 321: 867.
13. 0 interacts with negatively charged phospholipid bilayers. J. Biol. Chem. 269: 10764.
14. D'Urso, D., P.J. Brophy, S.M. Staugaitis, C.S. Gillespie, A.B. Frey, J.G. Stempak, and D.R. Colman. 1990. Protein zero of peripheral nerve myelin: Biosynthesis, membrane insertion, and evidence for homotypic interaction. Neuron 2: 449.
15. Dyck, P.J., P. Chance, R. Lebo, and J.A. Carney. 1993. Hereditary motor and sensory neuropathies. In Peripheral neuropathy (ed. P.J. Dyck et al.), p. 1094. W.B. Saunders, Philadelphia.
16. Ellis, D. and S. Malcolm. 1994. Proteolipid protein gene dosage effect in Pelizaeus-Merzbacher disease. Nat. Genet. 6: 333.
17. 0 protein as a homophilic adhesion molecule. Nature 344: 871.
18. 0 mutations. Neurology (in press).
19. Garcia, C.A., R.E. Malamut, J.D. England, G.S. Parry, P. Liu, and J.R. Lupski. 1995. Clinical variability in two pairs of identical twins with the Charcot-Marie-Tooth disease type 1A duplication. Neurology 45: 2090.
20. Gow, A., V.L. Friedrich, Jr., and R.A. Lazzarini. 1994. Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J. Neurosci. Res. 37: 574.
21. Graf, W.D., P.F. Chance, M.W. Lensch, L.J. Eng, H.P. Lipe, and T.D. Bird. 1996. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A. Cancer 77: 1356.
22. Harati, Y. and I.J. Butler. 1985. Congenital hypomyelinating neuropathy. J. Neurol. Neurosurg, Psychiatry 48: 1269.
23. Harding, A.E. 1995. From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins. Brain 118: 809.
24. 0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nat. Genet. 5: 266.
25. Hayasaka, K., M. Himoro, Y. Wang, M. Takata, S. Minoshima, N. Shimizu, M. Miura, K. Uyemura, and G. Takada. 1993b. Structure and chromosomal localization of the gene encoding the human myelin protein zero (MPZ). Genomics 17: 755.
26. Hertz, J.M., A.D. Børglum, C.A. Brandt, T. Flint, and C. Bisgaard. 1994. Charcot-Marie-Tooth disease type 1A: The parental origin of a de novo 17p11.2-p12 duplication. Clin. Genet. 46: 291.
27. Hoogendijk, J.E., G.W. Hensels, A.A.W.M. Gabreels-Festen, FJ.M. Gabreëls, E.A.M. Janssen, P. De Jonghe, J.-J. Martin, C. Van Broeckhoven, L.J. Valentijn, F. Baas, M. De Visser, and P.A. Bolhuis. 1992. De novo mutation in hereditary motor and sensory neuropathy type I. Lancet 339: 1081.
28. Hudson, L.D., C. Puckett, J. Berndt, J. Chan, and S. Gencic. 1989. Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder. Proc. Natl. Acad. Sci. 86: 8128.
29. Huxley, C., E. Passage, A. Manson, G. Putzu, D. Figarella-Branger, J.F. Pellissier, and M. Fontés. 1996. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. MoL Genet. 5: 563.
30. Ikegami, T., G. Nicholson, H. Ikeda, A. Ishida, H. Johnston, G. Wise, R. Ouvrier, and K. Hayasaka. 1996. A novel homozygous mutation of the myelin Po gene producing Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Biochem. Biophys. Res. Commun. 222: 107.
31. Inoue, K., H. Osaka, N. Sugiyama, C. Kawanishi, H. Onishi, A. Nezu, K. Kimura, S. Kimura, Y. Yamada, and K. Kosaka. 1996. A duplicated PLP gene causing Pelizaeus-Merzbacher disease detected by comparative multiplex PCR. Am. J. Hum. Genet. 59: 32.
32. Ionasescu, V.V., R. Ionasescu, C. Searby, and D.F. Barker. 1993. Charcot-Marie-Tooth neuropathy type 1A with both duplication and non-duplication. Hum. Mol. Genet. 2: 405.
33. Ionasescu, V.V., R. Ionasescu, C. Searby, and R. Neahring. 1995a. Dejerine-Sottas disease with de novo dominant point mutation of the PMP22 gene. Neurology 45: 1766.
34. Ionasescu, V., C. Searby, R. Ionasescu, and W. Meschino. 1995b. New point mutations and deletions of the connexin 32 gene in X-linked Charcot-Marie-Tooth neuropathy. Neuromusc. Disord. 5: 297.
35. Kagawa, T., K. Ikenaka, Y. Inoue, S. Kuriyama, T. Tsujii, J. Nakao, K. Nakajima, J. Aruga, H. Okano, and K. Mikoshiba. 1994. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13: 427.
36. Kaku, D.A., G.J. Parry, R. Malamut, J.R. Lupski, and C.A. Garcia. 1993a. Nerve conduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurology 43: 1806.
37. _. 1993b. Uniform slowing of conduction velocities in Charcot-Marie-Tooth polyneuropathy type 1. Neurology 43: 2664.
38. Killian, J.M., P.S. Tiwari, S. Jacobson, R.D. Jackson, and J.R. Lupski. 1996. Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy. Muscle Nerve 19: 74.
39. Kiyosawa, H. and P. Chance. 1996. Primate origin of the CMT1A-REP repeat and analysis of a putative transposon-associated recombinational hotspot. Hum. Mol. Genet. 5: 745.
40. Kiyosawa, H., M.W. Lensch, and P.F. Chance. 1995. Analysis of the CMT1A-REP repeat: Mapping crossover breakpoints in CMT1A and HNPP. Hum. Mol. Genet. 4: 2327.
41. Kobayashi, H., E.P. Hoffman, and H.G. Marks. 1994. The rumpshaker mutation in spastic paraplegia. Nat. Genet. 7: 351.
42. Latour, P., F. Blanquet, E. Nelis, C. Bonnebouche, F. Chapon, P. Diraison, E. Ollagnon, A. Dautigny, D. Pham-Dinh, G. Chazot, M. Boucherat, C. Van Broeckhoven, and A. Vandenberghe. 1995. Mutations in the myelin protein zero gene associated with Charcot-Marie-Tooth disease type 1B. Hum. Mutat. 6: 50.
43. LeGuern, E., R. Gouider, N. Ravisé, J. Lopes, S. Tardieu, M. Gugenheim, N. Abbas, P. Bouche, Y. Agid, and A. Brice. 1996. A de novo case of hereditary neuropathy with liability to pressure palsies (HNPP) of maternal origin: A new mechanisn for deletion in 17p11.2? Hum. Mol. Gener. 5: 103.
44. LeGuern, E., R. Gouider, J. Lopes, N. Abbas, M. Gugenheim, S. Tardieu, N. Ravisé, J.-M. Léger, J.-M. Vallat, P. Bouche, Y. Agid, A. Brice, and the French CMT Collaborative Research Group. 1995. Constant rearrangement of the CMT1A-REP sequences in HNPP patients with a deletion in chromosome 17p11.2: A study of 30 unrelated cases. Hum. Mol. Genet. 4: 1673.
45. Lemke, G. 1988. Unwrapping the genes of myelin. Neuron 1: 535.
46. Liehr, T., B. Rautensirauss. H. Grehl, K.D. Bathke, A. Ekici, A. Rauch, and H.-D. Roll. 1996. Mosaicism for the Charcot-Marie-Tooth disease type 1A duplication suggests somatic reversion. Hum. Genet 98: 22.
47. Lopes, J., E. LeGuern, R. Gouider, S. Tardieu, N. Abbas, N. Birouk, M. Gugenheim, P. Bouche, Y. Agid, A. Brice, and the French CMT Collaborative Research Group. 1996. Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type IA repeat sequences: New tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A. Am. J. Hum. Genet. 58: 1223.
48. Lorenzetti, D., D. Pareyson, A. Sghirlanzoni, B.B. Roa, N.E. Abbas, M. Pandolfo, S. Di Donato, and J.R. Lupski. 1995. A 1.5-Mb deletion in 17p11.2-p12 is frequently observed in Italian families with hereditary neuropathy with liability to pressure palsies. Am. J. Hum. Genet. 56: 91.
49. Lupski, J.R. 1996. DNA diagnostics for Charcot-Marie-Tooth disease and related inherited neuropathies. Clin. Chem. 42:1.
50. Lupski, J.R. and C.A. Garcia. 1992. Molecular genetics and neuropathology of Charcot-Marie-Tooth disease type 1A. Brain Pathol. 2: 337.
51. Lupski, J.R., P.F. Chance, and C.A. Garcia. 1993a. Inherited primary peripheral neuropathies: Molecular genetics and clinical implications of CMT1A and HNPP. J. Am. Med. Assoc. 270: 2326.
52. Lupski, J.R., J.R. Roth, and G.M. Weinstock. 1996. Chromosomal duplications in bacteria, fruit flies, and humans. Am. J. Hum. Genet. 58: 21.
53. Lupski, J.R., C.A. Garcia, G.J. Parry, and P.I. Patel. 1991a. Charcot-Marie-Tooth polyneuropathy syndrome: Clinical, electrophysiologic, and genetic aspects. In Current neurology (ed. S. Appel), p. 1. Mosby-Yearbook, Chicago.
54. Lupski, J.R., L. Pentao, L.L. Williams, and P.I. Patel. 1993b. Stable inheritance of the CMT1A DNA duplication in two patients with CMT1 and NF1. Am. J. Med. Genet. 45: 92.
55. Lupski, J.R., C.A. Wise, A. Kuwano, L. Pentao, J.T. Parke, D.G. Gtaze, D.H. Ledbetter, F. Greenberg, and P.I. Patel. 1992. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1: 29.
56. Lupski, J.R., R. Montes de Oca-Luna, S. Slaugenhaupt, L. Pentao, V. Guzzetta, B.J. Trask, O. Saucedo-Cardenas, D.F. Barker, J.M. Killian, C.A. Garcia, A. Chakravarti, and P.I. Patel. 1991b. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66: 219.
57. Mancardi, G.L., A. Uccelli, E. Bellone, A. Sghirlanzoni, P. Mandich, D. Pareyson, A. Schenone, M. Abbruzzese, and F. Ajmar. 1994. 17p11.2 duplication is a common finding in sporadic cases of Charcot-Marie-Tooth type 1. Eur. Neurol. 34: 135.
58. Manfioletti, G., M.E. Ruaro, G. Del Sal, L. Philipson, and C. Schneider. 1990. A growth arrest-specific (gas) gene codes for a membrane protein. Mol. Cell. Biol. 10: 2924.
59. Mariman, E.C.M., A.A.W.M. Gabreels-Festen, S.E.C. van Beersum, L.J. Valentijn, F. Baas, P.A. Bolhuis, P.J.H. Jongen, H.H. Ropers, and F.J.M. Gabreels. 1994. Prevalence of the 1.5-Mb 17p deletion in families with hereditary neuropathy with liability to pressure palsies. Ann. Neurol. 36: 650.
60. Matsunami, N., B. Smith, L. Ballard, M.W. Lensch, M. Robertson, H. Albertsen, C.O. Hanemann, H.W. Müller, T.D. Bird, R. White, and P.F. Chance. 1992. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat. Genet. 1: 176.
61. Morgan, G.T. 1995. Identification in the human genome of mobile elements spread by DNA-mediated transposition. J. Mol. Biol. 254: 1.
62. Nathans, J. 1994. In the eye of the beholder: Visual pigments and inherited variation in human vision. Cell 78: 357.
63. Navon, R., B. Seifried, N.S. Gal-On, and M. Sadeh. 1996. A new point mutation affecting the fourth transmembrane domain of PMP22 results in a severe, de novo Charcot-Marie-Tooth disease. Hum. Genet. 97: 685.
64. Nelis, E., C. Van Broeckhoven, and the European CMT Consortium. 1996a. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: A European collaborative study. Eur. J. Hum. Genet. 4: 25.
65. Nelis, E., L.E. Warner, E. De Vriendt, P.F. Chance, J.R. Lupski, and C. Van Broeckhoven. 1996b. Comparison of single-strand conformation polymorphism (SSCP) and heteroduplex analysis (HA) for detection of mutations in CMT1 and related peripheral neuropathies. Eur. J. Hum. Genet. (in press).
66. Nicholson, G. 1995. Myelin gene dosage and mutation in the hereditary motor and sensory neuropathies: A review. J. Neurol. Neurosurg. Psychiatry 58: 523.
67. Nicholson, G.A., L.J. Valentijn, A.K. Cherryson, M.L. Kennerson, T.L. Bragg, R.M. DeKroon, D.A. Ross, J.D. Pollard, J.G. Mcleod, P.A. Bolhuis, and F. Baas. 1994. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. (Erratum Nat. Genet. 7: 113) Nat. Genet. 6: 263.
68. Olsson, J.E., J.W. Gordon, B.S. Pawlyk, D. Roof, A. Hayes, R.S. Molday, S. Mukai, G S. Cowley, E.L. Berson, and T.P. Dryja. 1992. Transgenic mice with a rhodopsin mutation (Pro23His): A mouse model of autosomal dominant retinitis pigmentosa. Neuron 9: 815.
69. Oosumi, T., W.R. Beiknap, and B. Garlick. 1995. Mariner transposons in humans. Nature 378: 672.
70. Oterino, A., F.I. Montón, V.M. Cabrera, F. Pinto, A. Gonzalez, and N.R. Lavilla. 1996. Arginine-164-tryptophan substitution in connexin32 associated with X linked dominant Charcot-Marie-Tooth disease. J. Med. Genet. 33: 413.
71. Ouvrier, R. 1996. Correlation between the histopathologic, genotypic, and phenotypic features of hereditary peripheral neuropathies in childhood. J. Child Neurol. 11: 133.
72. Palau, F., A. Lofgren, P. De Jonghe, S. Bort, E. Nelis, T. Sevilla, J.-J. Martin, J. Vilchez, F. Prieto, and C. Van Broeckhoven. 1993. Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A: Unequal nonsister chromatid exchange during spermatogenesis. Hum. Mol. Genet. 2: 2031.
73. Patel, P.I., B.B. Roa, A.A. Welcher, R. Schoener-Scott, B.J. Trask, L. Pemao, G.J. Snipes, C.A. Garcia, U. Francke, F.M. Shooter, J.R. Lupski, and U. Suter. 1992. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1: 159.
74. Pentao, L., C.A. Wise, A.C. Chinaull, P.I. Patel, and J.R. Lupski. 1992. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nat. Genet. 2: 292.
75. Raeymaekers, P., V. Timmerman, E. Nelis, P. De Jonghe, J.E. Hoogendijk, F. Baas, D.F. Barker, J.J. Martin, M. De Visser, P.A. Bolhuis, C. Van Broeckhoven, and the HMSN Collaborative Research Group. 1991. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT1a). Neuromusc. Disord. 1: 93.
76. Raskind, W.H., C.A. Williams, L.D. Hudson, and T.D. Bird. 1991. Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. Am. J. Hum. Genet. 49: 1355.
77. Readhead, C., A. Schneider, I. Griffiths, and K.-A. Nave. 1994. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12: 583.
78. Reisecker, F., F. Leblhuber, R. Lexner, G. Radner, W. Rosenkranz, and K. Wagner. 1994. A sporadic form of hereditary neuropathy with liability to pressure palsies: Clinical, electrodiagnostic, and molecular genetic findings. Neurology 44: 753.
79. Reiter, L.T., T. Murakami, T. Koeuth, L. Pentao, D.M. Muzny, R.A. Gibbs, and J.R. Lupski. 1996. A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transponson-like element. Nat. Genet. 12: 288.
80. Roa, B.B. and J.R. Lupski. 1994. Molecular genetics of Charcot-Marie-Tooth neuropathy. Adv. Hum. Genet. 22: 117.
81. Roa, B.B., U. Ananth, C.A. Garcia, and J.R. Lupski. 1995. Molecular diagnosis of CMT1A and HNPP. LabMedica Int. 12: 22.
82. Roa, B.B., P.J. Dyck, H.G. Marks, P.F. Chance, and J.R. Lupski. 1993a. Dejerine-Sottas syndrome associated with point mutation in the peripheral myetin protein 22 (PMP22) gene. Nat. Genet. 5: 269.
83. Roa, B.B., L.E. Warner, C.A. Garcia, D. Russo, R. Lovelace, P.F. Chance, and J.R. Lupski. 1996a. Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease. Hum. Mutat. 7: 36.
84. Roa, B.B., F. Greenberg, P. Gunaratne, C.M. Sauer, M.S. Lubinsky, C. Kozma, J.M. Meek, R.E. Magenis, L.G. Shaffer, and J.R. Lupski. 1996b. Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type 1A neuropathy. Hum. Genet. 97: 642.
85. Roa, B.B., C.A. Garcia, U. Suter, D.A. Kulpa, C.A. Wise, J. Mueller, A.A. Welcher, G.J. Snipes, E.M. Shooter, P.I. Patel, and J.R. Lupski. 1993b. Charcot-Marie-Tooth disease type 1A: association with a spontaneous point mutation in the PMP22 gene. N. Engl. J. Med. 329: 96.
86. Robertson, H.M., K.L. Zumpano, A.R. Lohe, and D.L. Hartl. 1996. Reconstructing the ancient mariners of humans. Nat. Genet. 12: 360.
87. Saugier-Veber, P., A. Munnich, D. Bonneau, J.-M. Rozet, M. Le Merrer, R. Gil, and O. Boespflug-Tanguy. 1994. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat. Genet. 6: 257.
88. Schneider, A., P. Montague, I. Griffiths, M. Fanarraga, P. Kennedy, P. Brophy, and K.-A. Nave. 1992. Uncoupling of hypomyehnation and glial cell death by a mutation in the proteolipid protein gene. Nature 258: 758.
89. Sereda, M., I. Griffiths, A. Puhlhofer, H. Stewart, M.J. Rossner, F. Zimmermann, J.P. Magyar, A. Schneider, E. Hund, H.-M. Meinck, U. Suter, and K.-A. Nave. 1996. A transgenic rat model of Charcot-Maire-Tooth disease. Neuron 16: 1049.
90. 0, the major structural protein of peripheral nerve myelin. Neuron (in press).
91. Smit, A.F.A. and A.D. Riggs. 1996. Tiggers and other DNA transposon fossils in the human genome. Proc. Natl. Acad. Sci. 93: 1443.
92. Snipes, G.J. and U. Suter. 1995. Molecular anatomy and genetics of myelin proteins in the peripheral nervous system. J. Anat. 186: 483.
93. Snipes, G.J., U. Suter, and E.M. Shooter. 1993. Human peripheral myelin protein-22 carries the L2/HNK-1 carbohydrate adhesion epitope. J. Neurochem. 61: 1961.
94. Snipes, G.J., U. Suter, A.A. Welcher, and E.M. Shooter. 1992. Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13)./. Celt Biol. 117: 225.
95. Sung, C.-H., B.C. Schneider, N. Agarwal, D.S. Papermaster, and J. Nathans. 1991. Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proc. Natl. Acad. Sci. 88: 8840.
96. Suter, U. and G.J. Snipes. 1995. Peripheral myelin protein 22: Facts and hypotheses. J. Neurosci. Res. 40: 145.
97. Suter, U., J.J. Moskow, A.A. Welcher, G.J. Snipes, B. Kosaras, R.L. Sidman, A.M. Buchberg, and E.M. Shooter. 1992a. A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc. Natl. Acad. Sci. 89: 4382.
98. Suter, U., A.A. Welcher, T. Özcelik, G.J. Snipes, B. Kosaras, U. Francke, S. Billings-Gagliardi, R.L. Sidman, and E.M. Shooter. 1992b. Trembler mouse carries a point mutation in a myelin gene. Nature 356: 241.
99. Tachi, N., N. Kozuka. K. Ohya, S. Chiba, K. Sasaki, K. Uyemura, and K. Hayasaka. 1996. A new mutation of the Po gene in patients with Charcot-Marie-Tooth disease type 1B: Screening of the Po gene by heteroduplex analysis. Neurosci. Lett. 204: 173.
100. Tan, C.C., P.J. Ainsworth, A.F. Hahn, and P.M. MacLeod. 1996. Novel mutations in the connexin 32 gene associated with X-linked Charcot-Mane-Tooth disease. Hum. Mutat. 7: 167.
101. Timmerman, V., P. De Jonghe, P. Spoelders, S. Simokovic, A. Lofgren, E. Nelis, J. Vance, J.-J. Martin, and C. Van Broeckhoven. 1996a. Linkage and mutation analysis of Charcot-Marie-Tooth neuropathy type 2 families with chromosomes 1p35-p36 and Xq13. Neurology 46: 1311.
102. Timmerman, V., A. Lofgren, E. Le Guern, P. Liang, P. De Jonghe, J.-J. Martin, D. Verhalle, W. Robberecht, R. Gouider, A. Brice, and C. Van Broeckhoven. 1996b. Molecular genetic analysis of the 17p11.2 region in patients with hereditary neuropathy with liability to pressure palsies (HNPP). Hum. Genet. 97: 26.
103. Timmerman, V., B. Rautenstrauss, L. Reiter, T. Koeuth, A. Lofgren, T. Liehr, E. Nelis, K.D. Bathke, P. DeJonghe, H. Grehl, J.-J. Martin, J.R. Lupski, and C. Van Broeckhoven. 1996c. Detection of the CMT1A/HNPP recombination hotspot in unrelated patients of European decent. J. Med. Genet. (in press).
104. Timmerman, V., E. Nelis, W. Van Hul, B.W. Nieuwenhuijsen, K.L. Chen, S. Wang, K. Ben Othman, B. Cullen, R.J. Leach, C.O. Hanemann, P. De Jonghe, P. Raeymaekers, G.-J.B. van Ommen, J.-J. Martin, H.W. Muller, J.M. Vance, K.H. Fischbeck, and C. Van Broeckhoven. 1992. The peripheral myelin protein gene PMP22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet. 1: 171.
105. Valentijn, L.J., F. Baas, I. Zorn, G.W. Hensels, M. de Visser, and P.A. Bolhuis. 1993. Alternatively sized duplication in Charcot-Marie-Tooth disease type 1A. Hum. Mol. Genet. 2:2143.
106. Valentijn, L.J., R.A. Ouvrier, N.H.A. van den Bosch, P.A. Bolhuis, F. Baas, and G.A. Nicholson. 1995. Déjérine-Sottas neuropathy is associated with a de novo PMP22 mutation. Hum. Mutat. 5:76.
107. Valentijn, L.J., F. Baas, R.A. Wolterman, J.E. Hoogendijk, N.H.A. van den Bosch, I. Zorn, A.A.W.M. Gabreëls-Festen, M. de Visser, and P.A. Bolhuis. 1992a. Identical point mutations of PMP22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat. Genet. 2:288.
108. Valentijn, L.J., P.A. Bolhuis, I. Zorn, J.E. Hoogendijk, N. van den Bosch, G.W. Hensels, V.P. Stanton, Jr., D.E. Housman, K.H. Fischbeck, D.A. Ross, G.A. Nicholson, E.J. Meershoek, H.G. Dauwerse, G.-J.B. van Ommen, and F. Baas. 1992b. The peripheral myelin gene PMP22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat. Genet. 1: 166.
109. Vance, J.M., G.A. Nicholson, L.H. Yamaoka, J. Stajich, C.S. Stewart, M.C. Speer, W.-Y. Hung, A.D. Roses, D. Barker, and M.A. Pericak-Vance. 1989. Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17. Exp. Neurol. 104: 186.
110. Verhalle, D., A. Löfgren, E. Nelis, I. Dehaene, P. Theys, M. Lammens, R. Dom, C. Van Broeckhoven, and W. Robberecht. 1994. Deletion in the CMT1A locus on chromosome 17p11.2 in hereditary neuropathy with liability to pressure palsies. Ann Neurol. 35: 704.
111. Warner, L.E., B.B. Roa, and J.R. Lupski. 1996a. Absence of PMP22 coding region mutations in CMT1A duplication patients: Further evidence supporting gene dosage as a mechanism for Charcot-Marie-Tooth disease type 1A. Hum. Mutat. 8: (in press).
112. 0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron (in press).
113. Wise, C.A., C.A. Garcia, S.N. Davis, Z. Heju, L. Pentao, P.I. Patel, and J.R. Lupski. 1993. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMT1A duplication. Am. J. Hum. Genet. 53: 853.
114. Yoshikawa, H. and P.J. Dyck. 1991. Uncompacted inner myelin lamellae in inherited tendency to pressure palsy. J. Neuropath. Exp. Neurol. 50: 649.
115. Yoshikawa, H., T. Nishimura, Y. Nakatsuji, H. Fujimura, M. Himoro, K. Hayasaka, S. Sakoda, and T. Yanagihara. 1994. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann. Neurol. 35: 445.